VolCT - Group 1B

From QIBA Wiki
Jump to navigation Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

Current Goals & Status:

  • Question: What is the minimum detectable level of change in patient datasets under a “No Change” condition?
    • AIMS: For patient datasets acquired over a very short time interval (“no change” condition”) investigate variance in measuring change in volume, diameter and bi-directional diameters of lesions
    • Investigate inter-observer variability in each task
    • Investigate Intra-observer variability in each task
    • Methods - Materials
      • Image Data from MSK Coffee Break Experiment
      • 32 NSCLC patients, imaged twice on same scanner over period < 15 minutes
      • Thin slice (1.25 mm thick) image data
      • Selected one lesion per patient
      • no outcome data
      • Publicly Available on NCIA
    • Methods - Readings
      • 5 readers
      • Read CT at timepoint 1, CT at timepoint 2 and repeat either CT timepoint 1 or timeoint 2 to assess intra-reader variability
    • Methods - Measurements
      • Measure Single Longest Diameter, manually (SLD)
      • Measure Longest Diameter and Perpendicular Diameter; take product to obtain Product of Diameters (POD)
      • Contour Full Boundary of lesion with semiautomated tool; calculate volume (Vol)
      • Extract other measures as well (SLD from POD measureement; SLD from VOl and POD from Vol).
    • The Order of Readers, Lesions and Measurement Methods were Randomized (Measurements done in Blocks of 10)
    • Analyses
      • Pooled Analysis across readers and lesions; Percent Difference between Scan 1 and Scan 2 for each measurement method
      • Subgroup Analyses: (a) Based on Measureable/Non-Measureable lesions identified by Mike O'Neal of CoreLabs; (b) Difficult, Moderate and Easy as Identified by Mike McNitt-Gray
  • Conference Paper on Reproducibility and Accuracy of Uni- and Bi-Dimensional Tumor Measurements from MRI and CT Volumes, which looks at RECIST, WHO and Volume measurements.